Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
24,446 total articles
Microchip Technology's Nantes facility in France has expanded its MIL-PRF-38535 QML certification to include Class Y, enhancing its ability to produce high-reliability semiconductors for aerospace and defense applications. This expansion supports advanced packaging technologies and next-generation military and space programs, strengthening Microchi…
Enphase Energy has introduced the IQ9N Microinverters equipped with advanced gallium nitride (GaN) technology, targeting residential solar customers in Europe. These microinverters offer high efficiency (up to 97.95%), enhanced energy production from high-power solar panels, and a 25-year warranty. The product supports improved reliability, cooler …
Chaince Digital Holdings Inc. announced that its Board has approved a long-term strategic initiative to explore extending its data center and computing infrastructure into space-related applications. The company plans to evaluate four focus areas: space-based data centers, AI and HPC infrastructure, ultra-low-temperature quantum cooling systems, an…
DoubleVerify has launched an AI-powered brand suitability reporting tool specifically for YouTube Audio Ads campaigns. This new offering extends their proven post-bid measurement capabilities to audio-first ad environments, enabling advertisers to maintain brand safety and optimize performance as they increasingly invest in audio media. The tool le…
Flyte, a regional air mobility subsidiary of Catheter Precision, Inc. (NYSE American: VTAK), has expanded its strategic relationship with Volato Group's Vaunt private aviation platform. This collaboration unlocks new revenue streams by monetizing repositioning flights and increasing aircraft utilization across Flyte's Cirrus Vision Jet fleet. The p…
OraSure Technologies announced FDA clearance for its Colli-Pee™ Dx Urine Collection Kit, enabling convenient at-home urine sample collection for testing multiple STIs on Roche's cobas® molecular diagnostic platforms. This approval enhances patient access and privacy, facilitates decentralized testing, and supports public health screening programs b…
Viasat, Inc. announced it has been awarded a prime contract by the U.S. Space Force to build and deliver a fleet of small, maneuverable dual-band GEO satellites under the Protected Tactical SATCOM-Global (PTS-G) program. This multi-year award includes satellite production, launch, ground operations, and sustainment services, leveraging Viasat's adv…
Rezolve Ai PLC reveals that 70% of shoppers complete purchases after a single search, a rise from 60% in 2025, indicating a shift towards conversational commerce and a zero-click economy. Long-form queries have increased significantly while traditional multi-page browsing and filter usage decline. Rezolve Ai positions its Brain Suite enterprise AI …
Teads Holding Co. has launched EngageOS, the industry's first unified publisher feed operating system that uses AI to combine editorial and programmatic demand into a single auction, maximizing total revenue per user session without compromising audience loyalty. The platform includes a strategic partnership with Magnite, integrating third-party pr…
ZenaTech, Inc. announced it has signed an offer to acquire a Western Canadian land surveying company to strengthen its Drone as a Service (DaaS) presence in the geospatial sector serving infrastructure, utilities, forestry, mining, and agriculture industries. Leveraging advanced AI drones and BVLOS capabilities within a progressive Canadian regulat…
Vera Bradley announced its first quarter fiscal 2027 financial results showing 7.8% revenue growth to $55.7 million, the first quarterly sales growth since FY2022. The company improved gross margin by 430 basis points, reduced expenses by nearly 15%, and decreased operating loss by 76% compared to last year. Strategic initiatives under Project Suns…
Kustom Entertainment, Inc. revealed plans during a press conference to host 20+ live music and festival events at Gilley's Gambling Hall in Park City, Kansas beginning in Fall 2026, with Country Stampede Kansas 2027 scheduled for June 25-27, 2027. The company aims to diversify genres and enhance live entertainment experiences in the Wichita region,…
Rein Therapeutics has expanded its Phase 2 RENEW clinical trial for LTI-03, a novel inhaled peptide therapy targeting idiopathic pulmonary fibrosis (IPF), by enrolling its first patient in the United Kingdom. With 16 patients enrolled to date across the US, Australia, and the UK, the company plans to add two more countries to the trial soon. The st…
Magnite, the largest independent sell-side advertising company, announced the launch of Magnite Orchestration, a new coordination layer that enables automated agent-to-agent transactions leveraging AI to optimize media buying and selling. The platform integrates buyer agents with Magnite’s seller agents, allowing for enhanced discovery and activati…
NXP Semiconductors N.V. announced the approval of a $1.014 per share interim dividend for the second quarter of 2026, to be paid in July. This move signals the company's robust capital structure, confidence in its long-term growth and strong cash flow. The dividend is part of NXP's ongoing capital return program and affects shareholders of record a…
Bionano Genomics announced that 13 studies published in 2026 demonstrate the effectiveness of its optical genome mapping (OGM) technology in detecting structural genetic variants relevant to reproductive health and prenatal genetic disorders. These independent studies, involving over 700 samples, show OGM's superior ability to identify genetic caus…
InspireMD reported 30-day positive outcomes from its CGUARDIANS II clinical trial evaluating the CGuard Prime 80 cm carotid stent used in transcarotid artery revascularization (TCAR) procedures. The study demonstrated 100% acute device success without major adverse events such as death, stroke, or myocardial infarction. The company expects potentia…
VenHub Global, Inc. announced new features to improve its autonomous Smart Store shopping experience, including mobile web shopping without app downloads, guest checkout, and increased order capacity with intelligent multi-bin fulfillment. These innovations aim to simplify and speed up shopping, supporting a growing international customer base and …
Theriva Biologics announced that Phase 1 clinical trial results of VCN-01, an oncolytic adenovirus, in heavily pre-treated refractory head and neck squamous cell carcinoma patients have been published in Clinical Cancer Research. The trial demonstrated prolonged overall survival and tumor resensitization to the immune checkpoint inhibitor durvaluma…
3 E Network Technology Group Limited announced a strategic framework agreement with California-based Aladdin Alaris AI to co-develop next-generation smart healthcare and eldercare robots. The collaboration combines 3 E Network's semiconductor and edge AI chip expertise with Aladdin Alaris AI's robotics hardware and software capabilities. They aim t…
Swarmer, a NASDAQ-listed drone autonomy software company, shared a letter from Chairman Erik Prince discussing the company's strategic shift toward becoming a platform that acquires and partners with battlefield-proven defense technology firms. With its software proven in over 100,000 combat missions in Ukraine, Swarmer aims to capitalize on growin…
Immuneering Corporation has dosed the first patient in the global pivotal Phase 3 MAPKeeper 301 trial, evaluating the efficacy and safety of atebimetinib plus modified gemcitabine/nab-paclitaxel (mGnP) compared to standard GnP alone in first-line metastatic pancreatic cancer patients. The trial aims to improve overall survival and quality of life f…
Medicus Pharma Ltd. (NASDAQ: MDCX) announced submission of an Investigational New Drug (IND) application to initiate PRECISION-E2, a first-of-its-kind Phase 2a clinical trial integrating genomics to evaluate Teverelix® for symptomatic endometriosis in women in the UAE. The study combines clinical, hormonal, pharmacokinetic, and genomic data from pa…
Helus Pharma, a clinical-stage pharmaceutical company specializing in novel serotonergic agonists (NSAs) for mental health conditions, announced that its Chief Medical Officer, Amir Inamdar, will participate in a fireside chat at the H.C. Wainwright 7th Annual Neuro Perspectives Conference. The company highlighted its lead drug candidates HLP003 in…
Rafael Holdings reported its Q3 fiscal 2026 financial results, highlighting the completion of the last patient last visit in its pivotal Phase 3 trial for Trappsol® Cyclo™, a treatment for Niemann-Pick Disease Type C1 (NPC). The company plans to submit a New Drug Application (NDA) in the second half of 2026, aiming to enter the commercial stage. Fi…
